VITTI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 26.260
EU - Europa 15.576
AS - Asia 3.536
AF - Africa 501
SA - Sud America 63
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 15
Totale 45.985
Nazione #
US - Stati Uniti d'America 25.571
IT - Italia 6.908
SE - Svezia 2.450
CN - Cina 1.956
DE - Germania 1.863
BG - Bulgaria 1.167
AT - Austria 764
GB - Regno Unito 701
CA - Canada 668
TR - Turchia 535
UA - Ucraina 432
VN - Vietnam 407
FI - Finlandia 370
CI - Costa d'Avorio 282
FR - Francia 214
SG - Singapore 197
BE - Belgio 190
IN - India 163
SN - Senegal 144
CH - Svizzera 139
RU - Federazione Russa 134
HK - Hong Kong 124
NL - Olanda 50
GR - Grecia 46
NG - Nigeria 37
RO - Romania 28
AU - Australia 27
PL - Polonia 27
BR - Brasile 26
JP - Giappone 26
KR - Corea 23
IE - Irlanda 21
ES - Italia 19
MY - Malesia 16
EG - Egitto 12
IR - Iran 12
EU - Europa 11
ZM - Zambia 11
CZ - Repubblica Ceca 10
TW - Taiwan 10
PY - Paraguay 9
CL - Cile 8
DK - Danimarca 8
JO - Giordania 8
MX - Messico 7
NZ - Nuova Zelanda 7
TH - Thailandia 7
UZ - Uzbekistan 7
CR - Costa Rica 6
CO - Colombia 5
EC - Ecuador 5
HR - Croazia 5
HU - Ungheria 5
ID - Indonesia 5
IL - Israele 5
PH - Filippine 5
ZA - Sudafrica 5
PK - Pakistan 4
RS - Serbia 4
SA - Arabia Saudita 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
AL - Albania 3
AR - Argentina 3
CY - Cipro 3
KE - Kenya 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
SM - San Marino 3
BH - Bahrain 2
BY - Bielorussia 2
DZ - Algeria 2
IQ - Iraq 2
IS - Islanda 2
JM - Giamaica 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MT - Malta 2
NO - Norvegia 2
SV - El Salvador 2
UY - Uruguay 2
VE - Venezuela 2
A1 - Anonimo 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BW - Botswana 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
MA - Marocco 1
ME - Montenegro 1
MN - Mongolia 1
MW - Malawi 1
NP - Nepal 1
PA - Panama 1
PR - Porto Rico 1
Totale 45.981
Città #
Woodbridge 3.391
Fairfield 3.261
Ann Arbor 2.468
Houston 2.392
Chandler 2.151
Ashburn 1.818
Seattle 1.356
Milan 1.310
Wilmington 1.198
Sofia 1.164
Cambridge 1.052
Beijing 750
New York 698
Ottawa 619
Vienna 616
Princeton 508
Serra 470
Lawrence 447
Izmir 445
Jacksonville 445
Medford 398
Nanjing 336
Des Moines 327
Rome 301
Abidjan 282
Florence 273
Dearborn 202
Brussels 181
Dong Ket 168
Boulder 154
San Diego 152
Pisa 151
Dakar 144
London 127
Frankfurt am Main 125
Falls Church 119
Redwood City 119
Bern 115
Nanchang 115
Bremen 114
Hong Kong 105
Jüchen 99
Lancaster 90
Kunming 78
Hebei 74
Naples 74
Shenyang 73
Marseille 70
Tianjin 59
Bologna 57
Detroit 56
Jiaxing 56
Changsha 54
Turin 54
Washington 54
Palermo 53
Hefei 51
Bari 49
Jinan 48
Düsseldorf 47
Brescia 45
Kocaeli 42
Nürnberg 39
Lagos 37
Norwalk 37
Catania 36
Dallas 33
Pune 33
Shanghai 33
Padova 32
Ningbo 31
Boardman 29
Chicago 29
Hangzhou 29
Phoenix 28
Napoli 26
Guangzhou 25
Istanbul 23
Sacile 23
Vicopisano 23
San Francisco 22
Los Angeles 21
Verona 21
Bergamo 20
Lanzhou 20
Torino 20
Indiana 19
Redmond 19
Chengdu 18
Zhengzhou 18
Helsinki 17
Toronto 17
Auburn Hills 16
Livorno 16
Mumbai 15
Munich 15
Orange 15
Genoa 14
Cagliari 13
Cosenza 13
Totale 32.745
Nome #
Tiroidite cronica autoimmune 4.195
Ontogenetic development of pancreatic thyrotropin-releasing hormone in human foetuses and in infants. 311
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. 203
Identification of a novel mutation in the polymerase delta 1 (POLD1) gene in a lipodystrophic patient affected by mandibular hypoplasia, deafness, progeroid features (MDPL) syndrome 177
Leonardo da Vinci "Design of Lady with Graves' disease" (1452-1519) 175
The presence of a tall cells>10% in a classical variant of papillary thyroid carcinoma (CV-PTC) makes its aggressiveness similar to that of tall cell variant (TCV-PTC) 173
Natural history of graves’ orbitopathy after treatment 170
In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer 169
Sera of patients with idiopathic myxedema contain IgG which block TSH-stimulated thyroid adenylate cyclase 166
Expression of the microsomal antigen on the surface of continuously cultured rat thyroid cells is modulated by thyrotropin. 161
null 160
A study on the relationship between intraglandular arterial distribution and thyroid lobe shape: implications for biotechnology of a bioartificial thyroid 159
Role of the underlying thyroid disease on the phenotype of graves' orbitopathy in a tertiary referral center 159
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation 159
null 157
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 155
Effects of bariatric surgery on preclinical myocardial alterations in severe obesity 153
Presence in the pre-surgical fine-needle aspiration of potential thyroid biomarkers previously identified in the post-surgical one. 152
Causes and laboratory investigations of thyrotoxicosis 150
Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy 149
A patient with MEN1 and end‑stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantation 148
In vitro assay of thyroid disruptors affecting TSH-stimulated adenylate cyclase activity 147
Role of thyroid ultrasound in the diagnostic evaluation of thyroid nodules 145
Spontaneous improvement of untreated mild graves' ophthalmopathy: Rundle's curve revisited. 145
Proteomic analysis of fine-needle aspiration in differential diagnosis of thyroid nodules. 145
Could improved ultrasound and power Doppler replace thyroidal radioiodine uptake to assess thyroid disease? 144
Hepatic left lobe volume is a sensitive index of metabolic improvement in obese women after gastric banding 144
V804M RET MUTATION AND VANDETANIB RESPONSE IN METASTATIC MEDULLARY THYROID CANCER 143
Results of Vardenafil Mediated Power Doppler Ultrasound, Contrast Enhanced Ultrasound and Systematic Random Biopsies to Detect Prostate Cancer 142
Thyrotropin stimulation of the ADP-ribosyltransferase activity of bovine thyroid membranes. 141
Radioactive iodine (131I) effects on male fertility 141
Prevalence of thyroid peroxidase, thyroglobulin and thyrotropin receptor antibodies in a long-term follow-up of juvenile Graves disease 140
Treatment of advanced thyroid cancer with targeted therapies: Ten years of experience 140
Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis. 138
A ganglioneuroma with features of a thyroid nodule: intense pain on fine needle biopsy as a diagnostic clue 138
Interference of serum thyroglobulin in the radioassay for serum antithyroglobulin antibodies. 137
Thyroid-stimulating antibody mimics thyrotropin in its ability to desensitize the adenosine 3',5'-monophosphate response to acute stimulation in continuously cultured rat thyroid cells (FRT-L5). 137
Recent advances in the understanding of humoral and cellular mechanisms implicated in thyroid autoimmune disorders. 137
null 137
Diagnosis of thyroid dysfunction: present and future. 136
Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves’ orbitopathy (GO): a new frontier for GO treatment? 136
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients 136
Comparison between thyroid stimulating and tsh-binding inhibiting immunoglobulins of Graves' disease. 135
Agretti P, De Marco G, De Servi M, Marcocci C, Vitti P, Pinchera A, Tonacchera M.: Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation 134
Electric and magnetic fields do not modify the biochemical properties of FRTL-5 cells 134
Identification of two distinct molecular subtypes by digital RNA counting of "non-invasive follicular tumour with papillary-like nuclear features (NIFTP)" 134
STUDY OF POTENTIAL INHIBITORS OF THYROID IODIDE UPTAKE BY USING CHO CELLS STABLY EXPRESSING THE HUMAN SODIUM/IODIDE SYMPORTER (hNIS) PROTEIN 133
Activating thyrotropin receptor mutations in histologically heterogeneous hyperfunctioning nodules of multinodular goiter. 133
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 133
Could improved ultrasound and power Doppler replace thyroidal radioiodine uptake to assess thyroid disease? 132
Molecular interactions at the cell surface: role of glycoconjugates and membrane lipids in receptor recognition processes. 131
Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies. 131
The expression of platelet serotonin transporter (SERT) in human obesity 131
mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases 131
Thyroglobulin Antibodies (TgAb) Titer Spontaneously Decrease Until The Negativization Or Stabilization In Most Of Cases Of Papillary Thyroid Microcarcinoma (mPTC) Treated With Total Thyroidectomy But Not Ablated With 131I 130
Authors’ Response: Haptoglobin and Body Mass Index 130
Assessment of nodular goitre 129
Ultrasonographic evaluation of liver volume and the metabolic syndrome in obese women 128
Binding of thyroglobulin (Tg) to the low-density lipoprotein receptor-associated protein (RAP) during the biosynthetic pathway prevents premature Tg interactions with sortilin 128
Artificial neural networks in the outcome prediction of adjustable gastric banding in obese women. 128
Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfected in CHO cells. 127
Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter 127
Significance of low levels of thyroglobulin autoantibodies associated with undetectable thyroglobulin after thyroidectomy for differentiated thyroid carcinoma 127
Hypertension, nausea, anorexia and weight loss were significantly associated with better progression-free survival in patients with radioiodine-Refractory Differentiated Thyroid Carcinoma treated with Lenvatinib 127
Iodine deficiency from pregnancy to childhood 127
Graves' IgG stimulation of continuously cultured rat thyroid cells: a sensitive and potentially useful clinical assay. 126
Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease. 126
A TSHr-LH/CGr Chimera that Measures Functional TSAb in Graves' Disease. 126
The spectrum of thyroid disorders in an iodine deficient community: the Pescopagano survey 126
Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years. 125
Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay. 124
Interventional bronchoscopy in the treatment of tracheal obstruction secondary to advanced thyroid cancer 124
null 124
Iodine contributes to thyroid autoimmunity in humans by unmasking a cryptic epitope on thyroglobulin. 124
Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease 123
Appearance of thyroid stimulating antibody and Graves' disease after radioiodine therapy for toxic nodular goitre. 123
Percutaneous ethanol injection: what is its role in the management of nodular lesions of endocrine glands? 121
Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage. 121
null 121
A Fast Method to Detect Cell Surface Expression of Thyrotropin Receptor (TSHr): The Microchip Flow Cytometry Analysis 121
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) 121
Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves' ophthalmopathy treated successfully with glucocorticoids themselves 120
Real-Time Elastosonography: Useful Tool for Refining the Presurgical Diagnosis in Thyroid Nodules with Indeterminate or Nondiagnostic Cytology 120
Lenvatinib therapy in progressive, radioiodine-refractory, differentiated thyroid carcinoma: analysis of 74 cases followed in a single centre 120
Thyroid volume in children: role of iodine intake. 119
Lung recurrence of papillary thyroid cancer diagnosed with antithyroglobulin antibodies after 10 years from initial treatment. 119
Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years. 119
Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease. 118
Active Surveillance In Papillary Thyroid Microcarcinomas (PMCS): A 2 Years Follow Up (FU) At A Single Center 118
Non-palpable thyroid nodules in a borderline iodine-sufficient area: detection by ultrasonography and follow-up. 117
HYPERTHYROIDISM AND PREGNANCY. AN ITALIAN THYROID ASSOCIATION (AIT) AND ITALIAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS (AME) JOINT STATEMENT FOR CLINICAL PRACTICE 117
Serum concentrations of adiponectin and leptin in patients with thyroid dysfunctions 117
Identification and functional studies of two new dual-oxidase 2 (DUOX2) mutations in a child with congenital hypothyroidism and a eutopic normal-size thyroid gland 117
An idic(15) associated with POF (premature ovarian failure): Molecular cytogenetic definition of a case and review of the literature. 116
Successo terapeutico di Lenvatinib in seconda linea in un caso di carcinoma follicolare della tiroide avanzato 116
Interleukin-6: a marker of thyroid-destructive processes? 115
Thyroid volume and urinary iodine in European schoolchildren: standardization of values for assessment of iodine deficiency. 114
THE LOCATION AND THE REGULATION OF THE TYPE I-IODOTHYRONINE 5'-MONODEIODINASE (TYPE I-MD) IN THE RAT-THYROID - STUDIES USING A SPECIFIC ANTI-TYPE I-MD ANTIBODY 114
null 114
null 114
Totale 17.750
Categoria #
all - tutte 97.522
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.522


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193.840 0 0 0 0 0 0 0 116 265 1.093 1.272 1.094
2019/20209.442 1.065 673 611 656 968 1.031 1.095 772 899 616 843 213
2020/20214.134 417 276 326 208 398 285 243 407 342 383 266 583
2021/20225.807 110 233 135 379 1.190 827 172 260 463 361 238 1.439
2022/20238.221 845 941 577 644 812 911 251 670 1.351 204 722 293
2023/20245.408 886 651 716 472 822 1.001 370 490 0 0 0 0
Totale 46.766